pre-measure study: assessing the role of ngs mrd in patients with aml receiving sct
Published 10 months ago • 80 plays • Length 0:48Download video MP4
Download video MP3
Similar videos
-
1:22
methods to measure mrd & its role in predicting patient outcomes in aml
-
2:00
mrd detection with ngs for aml: a new era of diagnostics
-
2:05
mrd in aml clinical practice
-
3:10
the role of ngs in mds diagnosis
-
5:33
clinical utility of the homologous recombination deficiency score in aml & mds
-
1:46
standardization mrd monitoring in clinical trials
-
0:44
the clinical meaning of mrd below the threshold of mcr in aml
-
1:02
the impact of sequencing in aml
-
5:08
treatment plan evaluation
-
3:18
midiagnostics' complete blood count (cbc) - blood analysis for diagnosis and monitoring
-
3:39
controlling mrsa by dna sequencing - sanger institute
-
0:48
an introduction to the maxilus study: the optimal dose of luspatercept in lr-mds
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:11
targeted rna-sequencing for the quantification of mrd in aml
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:45
role for mrd assessment in al amyloidosis?
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
1:05
using whole genome sequencing to identify novel predictors for sct in patients with mds
-
1:49
bringing precision medicine and mrd into clinical strategies
-
2:47
molecular background studies to aid diagnosis and treatment of mds
-
1:04
mp0533, a cd3-engaging darpin, in r/r aml or mds/aml: preliminary results of a phase i/iia trial
-
2:10
error-corrected dna sequencing for mrd detection